Relationship between F-18 florbetapir uptake in occipital lobe and neurocognitive performance in Alzheimer’s disease
Purpose To determine the association between occipital amyloid-PET uptake and neurocognitive performance in Alzheimer’s disease (AD). Materials and methods Fifty-eight participants with normal aged, mild cognitive impairment (MCI) due to AD and AD subjects who underwent F-18 florbetapir brain PET/CT...
Saved in:
Published in | Japanese journal of radiology Vol. 39; no. 10; pp. 984 - 993 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Singapore
Springer Singapore
01.10.2021
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Purpose
To determine the association between occipital amyloid-PET uptake and neurocognitive performance in Alzheimer’s disease (AD).
Materials and methods
Fifty-eight participants with normal aged, mild cognitive impairment (MCI) due to AD and AD subjects who underwent F-18 florbetapir brain PET/CT scans were divided into four groups (A, normal; B, MCI; C, mild AD; and D, moderate/severe AD). Semiquantitative analyses of SUVR images were performed. The differences between groups and the correlations between florbetapir uptake and Thai Mental State Examination (TMSE) scores were determined. Significant differences were defined using a
P
< 0.001, uncorrected, or a
P
< 0.05, FWE for the voxel-based analyses with Statistical Parametric Mapping (SPM).
Results
There was a slightly higher florbetapir uptake in the precuneus, parietal, and occipital association cortices in Group B > A. The occipital florbetapir uptake in Groups C and D was significantly higher than in Group A, in addition to the precuneus, anterior cingulate, posterior cingulate, temporoparietal, and frontal cortices. There was a strong negative correlation between TMSE scores and florbetapir uptake in the occipital lobe.
Conclusions
Occipital amyloid uptake is associated with clinically advanced AD, and is inversely correlated with neurocognitive performance and may be useful for evaluating AD severity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1867-1071 1867-108X 1867-108X |
DOI: | 10.1007/s11604-021-01132-6 |